MarketWatch

Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension

The MarketWatch News Department was not involved in the creation of this content. Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. ("Recor"), a wholly owned subsidiary of Otsuka ...
MarketWatch

CMS Issues National Coverage Determination for Recor Medical's Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

The MarketWatch News Department was not involved in the creation of this content. Palo Alto, CA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. ("Recor") and its parent company, Otsuka Medical ...
Business Insider

First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension with Ultrasound Renal Denervation

Palo Alto, CA, July 25, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the first patients in ...
The American Journal of Managed Care

FDA Approves Recor Medical's Paradise Ultrasound Renal Denervation System

A version of this article was published by HCPLive®. This version has been lightly edited. The FDA has approved the Paradise Ultrasound Renal Denervation (uRDN) system for the treatment of ...
KXAN

Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled ...

Palo Alto, CA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced U.S. Centers for ...
KRON4 News

First Medical Device Approved in Japan for the Treatment of Hypertension

Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal ...
KTLA

CMS Approves Additional Payment for Recor Medical’s Paradise™ Ultrasound Renal Denervation System in Hospital Inpatient Cases

Palo Alto, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced today that the Centers for ...
Business Wire

Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announce the U.S. Food and Drug Administration ...
Business Wire

ReCor Medical and Otsuka Medical Devices Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S ...

PALO ALTO, Calif.--(BUSINESS WIRE)--ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the filing of the pre-market ...
News Medical

ReCor gets FDA IDE approval to evaluate ReCor Paradise Renal Denervation System in patients with hypertension

ReCor Medical announced today that it has received FDA IDE approval for the RADIANCE-HTN clinical trial to evaluate the effect of the ReCor Paradise ® Renal Denervation System on blood pressure in ...